SlideShare a Scribd company logo
Hair mercury and urinary cadmium 
levels in Belgian children and their 
mothers within the framework of 
the COPHES/DEMOCOPHES projects
C. Pirard1, G. Koppen2, K. De Cremer3, I. Van 
Overmeire3, M.C. Dewolf4, E. Van De Mieroop5, D. 
Aerts6, P. Biot6, J. Van Loco3, C. Charlier1, the COPHES 
coordination team
1 CHU of Liège, Laboratory

of Clinical, Forensic and Environmental Toxicology
2 Flemish Institute of Technological Research, Environmental Risk and Health unit
3 Scientific Institute of Public Health
4 Provincial Institute for Hygiene and Bacteriology (IPHB), Mons
5 Provincial Institute for Hygiene (PIH), Antwerp
6 Federal Public Service Health, Food chain safety and Environment
ISBM, 10/09/2013
INTRODUCTION:
The European projects DEMOCOPHES and COPHES
Harmonised protocols for the 
collection of comparable HBM 
data throughout Europe

Belgium, Cyprus, Czech Republic, 
Denmark, Germany, Hungary, Ireland, 
Luxembourg, Poland, Portugal, Romania, 
Slovakia, Slovenia, Spain, Sweden, 
Switzerland, the United Kingdom

17 European countries measured:
‐ Cadmium, Phthalate metabolites, 
cotinine and Bisphenol A in urine
‐ Mercury in hair
in children (6‐11 years) and their 
mothers (≤ 45 years)  N = 3688
ISBM, 10/09/2013
INTRODUCTION:
Cadmium and Mercury
URINARY CADMIUM
biomarker of long‐term cadmium exposure
Toxicity: known human carcinogen (IARC 1); accumulation in the 
kidneys  glomerular and tubular toxicity
Exposure: tobacco smoke and dietary intake 
HAIR MERCURY
90‐95% MeHg & 5‐10% inorganic Hg
Toxicity of organic mercury: high neurotoxicity 
Exposure to MeHg: dietary intake (fish and sea product)
Exposure to inorganic Hg: inhalation during occupational 
activities or from dental amalgam release
ISBM, 10/09/2013
DEMOCOPHES in Belgium
Population characteristics
MOTHER
CHILD
N
129
129
Girl
129 
63 (49%)
Boy
‐
66 (51%)
Age range (mean) > 45 yr (40yr)  6‐11 yr (8yr)
Smoker status
Present
12 (9%)
0 (0%)
Former
32 (25%)
0 (0%)
Never
85 (66%)
129 (100%)
ETS
‐ at home
Never
106 (91%)
112 (87%)
‐ elsewhere
Never
50 (43%)
68 (53%)
Residence area
Rural
65 (50.4%)
Urban
64 (49.6%)

Brussels

Dutch & French speaking

Sampling (2011‐2012)
‐ 1st morning urine in PP vessels
‐ 3 cm‐length hair from the scalp
Analyses
Urinary cadmium: ICP‐MS
Hair mercury: Flow Injection 
Mercury System (FIMS)
ISBM, 10/09/2013
RESULTS: CADMIUM
Population

N

LOQ

Positive 
GM µg/l 
samples (%) (µg/g creat)

Mother

125

0.01

99.2

Child

125

0.01

86.4

0.21
(0.18)
0.04
(0.04)

Range µg/l 
(µg/g creat)

N > health 
guidance 

<LOQ ‐ 1.10
(<LOQ ‐ 0.767)
<LOQ ‐ 0.320
(<LOQ ‐ 0.323)

2>HBM I
0>HBM I

Increased levels with age
Correlation between mother and her child
No correlation with active or passive smoking status (cotinine, 
ETS statement) but very low smoker rate
No correlation with consumption of food commonly suspected 
to show high cadmium levels, nor with local food consumption
Higher levels in people living in urban areas vs rural
ISBM, 10/09/2013
RESULTS: CADMIUM
Comparison with the results from European population 
participating to the DEMOCOPHES project

ISBM, 10/09/2013
RESULTS: CADMIUM
Country

Population

Belgium present study Women
Girls and boys
Belgium
Women
Bangladesh
Girls and boys
Women
Canada
Girls and boys (Inuit)
Women and men (Inuit)
France
Women (non‐smoker)
(ENNS)
Women (non‐smoker)
Germany (GerES IV)
Girls and boys
Germany (GerES III)
Women and men
Women and men (non‐smoker)
Japan
Women (unpolluted area)
Japan
Women
Sweden
Women (non‐smoker)
Thailand
Girls
Boys
Girls and boys
United States
Girls and boys
(NHANES)
Women and men
United States
Girls and boys
(NHANES)
Women and men

N
125
125
541
320
444
16
24
157
319
1734
4740
3128
2332
3512
57
422
427
600
3053
3251
776
918

Age (yr)     GM or med
µg/l
mean 
40 [18‐45]
0.21
 8 [6‐12]
0.04
40.1 [18‐80] 0.22
5
0.31
27 [18‐43]
0.55
 [9‐14]
2.29
 [20‐39]
0.80
[18‐39]
0.29
[40‐49]
0.33
[3‐14]
0.08
0.22
[18‐69]
[18‐69]
0.20
48.1 [30‐60] 1.19
[41‐50]
1.01
38 [20‐50]
0.18*
[9‐15]
0.13*
[9‐15]
0.12*
[ 9‐12]
0.12*
  [6‐11]
0.10
 [30‐39]
0.28
0.08
 [6‐12]
[35‐50]
0.28

References
Present study
Hoet et al., 2013
Kippler et al., 2010
Benedetti et al., 1992
Fréry et al., 2011
Schulz et al., 2009
Wilhem et al., 2004 
Fukui et al., 2004
Moriguchi et al., 2005
Julin et al., 2011
Chaiwong et al., 2009
* µg/g creat
Paschal et al., 2000
Richter et al., 2009
ISBM, 10/09/2013
RESULTS: MERCURY
Population

N

LOQ

Mother

129

0.08

Positive 
samples (%)
95.3

Child

127

0.08

80.3

GM         
Range           N > health guidance 
µg/g
µg/g
0.38
<LOQ ‐ 1.969
2 > 1.9 µg/g
12 > 1 µg/g
0.20
(<LOQ ‐ 1.995)
1 > 1.9 µg/g
6 > 1 µg/g

No increase with age but mother > child
Correlation between mother and her child
No correlation with active or passive smoking status (cotinine, ETS 
statement), gender, hair treatment
Higher levels in children living in urban areas vs rural
Importance of the frequency of fish (sea or freshwater fish), 
shellfish and other seafood products
Increase with the number of dental amalgam fillings 
ISBM, 10/09/2013
RESULTS: MERCURY
Comparison with the results from European population 
participating to the DEMOCOPHES project

µg Hg/g hair

Present study: 0.28 µg/g

ISBM, 10/09/2013
RESULTS: MERCURY
FREQUENCY OF FISH 
CONSUMPTION
GM: 5.41 µg/g
> 4/week
GM: 1.47 µg/g
3 ‐ 4/week
GM: 0.61 µg/g
1 ‐ 2/week
GM: 0.34 µg/g
0 ‐ 1/week

Present study: 0.28 µg/g

GM: 0.25 µg/g
< 1/month
0

1

2

3

4
5
10
HAIR MERCURY LEVEL

20

30

40 µg/g

Abdelouahab et al., 2008; Barbosa et al., 1997 and 2001; Batista et al., 1996; Bjornberg et al., 2003; Chien et al., 2010; 
Cordier et al., 1998; De Wolf et al., 2009; Dickman et al., 1999; Diez et al., 2008 and 2011; Dolbec et al., 2001; Dorea et al., 
2003; Dunn et al., 2008; Elhamri et al., 2007; Foo et al., 1988; Fréry et al., 2011; Gaggi et al., 1996; Gerstenberger et al., 
1997; Hajeb et al., 2008; Harada et al., 1998; Holsbeek et al., 1996; Ip et al., 2004; Johnsson et al., 2004; Karouna‐Renier et 
al., 2008; Kim et al., 2008; Kruzikova et al., 2008; Kyle et al., 1982; Leino and Lodenius, 1995; McDowell et al., 2004; 
Monrroy et al., 2008; Montuori et al., 2006 Myers et al., 2000 and 2003; Okati et al., 2012; Oskarsson et al., 1990 and 1994; 
Pinheiro et al., 2005; Reis et al., 2009; Shao et al., 2013; Stern et al., 2001;Wranova et al., 2008.
ISBM, 10/09/2013
CONCLUSIONS:  
The Belgian urinary Cd and hair Hg results from the DEMOCOPHES 
project: 129 children (6‐11yr) and their mothers (≤ 45 years) 
The main determinants for levels of children and mothers were:
for urinary cadmium: the age and the urban or rural character 
of the residence place
for hair mercury: fish consumption and the number of dental 
amalgam fillings
Compared to health‐based guideline values: 

ISBM, 10/09/2013
CONCLUSIONS:  
The Belgian urinary Cd and hair Hg results from the DEMOCOPHES 
project: 129 children (6‐11yr) and their mothers (≤ 45 years) 
Compared to health‐based guideline values: 
Urinary cadmium levels
Source
WHO
JECFA
CSTEE
German HBM for adults
German HBM for children
BE
Others BMDL

Exposure guidance values
Related health effects
5 µg/g creat
Renal dysfunctions in workers
2.5 µg/g creat
Tubular dysfunctions 
2 µg/g creat
Renal dysfunctions
HBM‐I: 1 µg/l                Renal dysfunctions in adults
HBM‐II: 4 µg/l
HBM‐I: 0.5 µg/l              Renal dysfunctions in children
HBM‐II: 2 µg/l
1.7 ‐ 2 µg/g creat
0.6‐1.1 µg/g creat

Kidney toxicity
Glomerular and tubular dysfunctions

Urinary cadmium levels: less than 1% > HBM‐I
ISBM, 10/09/2013
CONCLUSIONS:  
The Belgian urinary Cd and hair Hg results from the DEMOCOPHES 
project: 129 children (6‐11yr) and their mothers (≤ 45 years) 
Compared to health‐based guideline values: 
Hair mercury levels

Hg level (µg/g)

5

4.6

4.2

3.8

3.4

3

JECFA

2.6

1.8

1.4

1

0.6

US EPA

2.2

90
80
70
60
50
40
30
20
10
0

0.2

Number of participants

Source Exposure guidance values Related health effects
References
WHO
7 µg/g hair
‐
WHO, 2008
Neurodevelopmental effects associated  JECFA, 2012
JECFA
1.3 µg/kg/week
with in utero exposure
Neurodevelopmental effects associated  US EPA, 2001
US EPA
0.1 µg/kg/day
with in utero exposure
Cognitive deficit in 7‐year‐old children with Grandjean et al., 1997 
Others
<10 µg/g hair
prenatal exposure

Mothers: 9% > 1 µg/g hair
Children:  5% > 1 µg/g hair
Mothers & children: 
1% > 1.9 µg/g hair
ISBM, 10/09/2013
ACKNOWLEGDMENTS
o The COPHES project was funded by the 7th Framework 
Programme (DG Research – No. 244237)
o The DEMOCOPHES project was co‐funded by the LIFE+ 
programme (DG Environment‐LIFE09 ENV/BE000410) and by the 
Belgian Joint Interministerial Conference on Environment and 
Health
o Thanks to all of the project partners for their support 
especially the Belgian team
o Thank you all for your attention

ISBM, 10/09/2013

More Related Content

Viewers also liked

K1 K. Straif
K1 K. StraifK1 K. Straif
K1 K. Straif
Kate Jones
 
14.1 - L.Leese
14.1 - L.Leese14.1 - L.Leese
14.1 - L.Leese
Kate Jones
 
6.2 schettgen
6.2 schettgen6.2 schettgen
6.2 schettgen
Kate Jones
 
A.3 Van Overmeire
A.3 Van OvermeireA.3 Van Overmeire
A.3 Van Overmeire
Kate Jones
 
13.2 M. Bader
13.2 M. Bader13.2 M. Bader
13.2 M. Bader
Kate Jones
 
Boxall
BoxallBoxall
Boxall
Kate Jones
 

Viewers also liked (6)

K1 K. Straif
K1 K. StraifK1 K. Straif
K1 K. Straif
 
14.1 - L.Leese
14.1 - L.Leese14.1 - L.Leese
14.1 - L.Leese
 
6.2 schettgen
6.2 schettgen6.2 schettgen
6.2 schettgen
 
A.3 Van Overmeire
A.3 Van OvermeireA.3 Van Overmeire
A.3 Van Overmeire
 
13.2 M. Bader
13.2 M. Bader13.2 M. Bader
13.2 M. Bader
 
Boxall
BoxallBoxall
Boxall
 

Similar to 12.3 pirard

Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can HelpMarike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
THL
 
Mapping low intake of micronutrients across Europe
Mapping low intake of micronutrients across EuropeMapping low intake of micronutrients across Europe
Mapping low intake of micronutrients across Europe
Wouter de Heij
 
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Réseau LIEU (Liaison Entreprises-Universités)
 
Eapra snet 2018
Eapra snet 2018Eapra snet 2018
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
Alain van Gool
 
Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...
BARRY STANLEY 2 fasd
 
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
THL
 
Health, Climate and Innovation
Health, Climate and InnovationHealth, Climate and Innovation
Health, Climate and Innovation
Oscar David Sánchez
 
journal.pmed.1001903
journal.pmed.1001903journal.pmed.1001903
journal.pmed.1001903
Melanie Williams
 
International partnerships - Shining light on the neglected zoonoses
International partnerships - Shining light on the neglected zoonosesInternational partnerships - Shining light on the neglected zoonoses
International partnerships - Shining light on the neglected zoonoses
ILRI
 
Identifying and Prioritizing Chemicals with Uncertain Burden o
Identifying and Prioritizing Chemicals with Uncertain Burden oIdentifying and Prioritizing Chemicals with Uncertain Burden o
Identifying and Prioritizing Chemicals with Uncertain Burden o
MalikPinckney86
 
Identifying and prioritizing chemicals with uncertain burden o
Identifying and prioritizing chemicals with uncertain burden oIdentifying and prioritizing chemicals with uncertain burden o
Identifying and prioritizing chemicals with uncertain burden o
ssuser47f0be
 
Oms oxigenoterapia
Oms oxigenoterapiaOms oxigenoterapia
Oms oxigenoterapia
Juan Londoño Ruíz
 
European Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparednessEuropean Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparedness
European Center for Disease Prevention and Control (ECDC)
 
Case control study.pdf
Case control study.pdfCase control study.pdf
Case control study.pdf
Deput Putri
 
Emergency Interventions: The use of Oxygen
Emergency Interventions: The use of OxygenEmergency Interventions: The use of Oxygen
Emergency Interventions: The use of Oxygen
SMACC Conference
 
European Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory DiseasesEuropean Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory Diseases
Global Risk Forum GRFDavos
 
ILRI and ACIAR One Health related research activities in Lao PDR
ILRI and ACIAR One Health related research activities in Lao PDRILRI and ACIAR One Health related research activities in Lao PDR
ILRI and ACIAR One Health related research activities in Lao PDR
ILRI
 
Speer survantacurosurf
Speer  survantacurosurfSpeer  survantacurosurf
Speer survantacurosurf
Mauricio Piñeros
 
Cyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. LedererCyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. Lederer
Human Variome Project
 

Similar to 12.3 pirard (20)

Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can HelpMarike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
Marike Kolossa-Gehring: The Chemical Challenge - How HBM4EU Can Help
 
Mapping low intake of micronutrients across Europe
Mapping low intake of micronutrients across EuropeMapping low intake of micronutrients across Europe
Mapping low intake of micronutrients across Europe
 
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
 
Eapra snet 2018
Eapra snet 2018Eapra snet 2018
Eapra snet 2018
 
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
 
Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...Alcohol intake and breast cancer in the European prospective investigation in...
Alcohol intake and breast cancer in the European prospective investigation in...
 
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)
 
Health, Climate and Innovation
Health, Climate and InnovationHealth, Climate and Innovation
Health, Climate and Innovation
 
journal.pmed.1001903
journal.pmed.1001903journal.pmed.1001903
journal.pmed.1001903
 
International partnerships - Shining light on the neglected zoonoses
International partnerships - Shining light on the neglected zoonosesInternational partnerships - Shining light on the neglected zoonoses
International partnerships - Shining light on the neglected zoonoses
 
Identifying and Prioritizing Chemicals with Uncertain Burden o
Identifying and Prioritizing Chemicals with Uncertain Burden oIdentifying and Prioritizing Chemicals with Uncertain Burden o
Identifying and Prioritizing Chemicals with Uncertain Burden o
 
Identifying and prioritizing chemicals with uncertain burden o
Identifying and prioritizing chemicals with uncertain burden oIdentifying and prioritizing chemicals with uncertain burden o
Identifying and prioritizing chemicals with uncertain burden o
 
Oms oxigenoterapia
Oms oxigenoterapiaOms oxigenoterapia
Oms oxigenoterapia
 
European Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparednessEuropean Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparedness
 
Case control study.pdf
Case control study.pdfCase control study.pdf
Case control study.pdf
 
Emergency Interventions: The use of Oxygen
Emergency Interventions: The use of OxygenEmergency Interventions: The use of Oxygen
Emergency Interventions: The use of Oxygen
 
European Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory DiseasesEuropean Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory Diseases
 
ILRI and ACIAR One Health related research activities in Lao PDR
ILRI and ACIAR One Health related research activities in Lao PDRILRI and ACIAR One Health related research activities in Lao PDR
ILRI and ACIAR One Health related research activities in Lao PDR
 
Speer survantacurosurf
Speer  survantacurosurfSpeer  survantacurosurf
Speer survantacurosurf
 
Cyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. LedererCyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. Lederer
 

More from Kate Jones

Craig Poland IOM
Craig Poland IOMCraig Poland IOM
Craig Poland IOM
Kate Jones
 
Guillaume Flament NIA
Guillaume Flament NIAGuillaume Flament NIA
Guillaume Flament NIA
Kate Jones
 
Sarah Mallagh HSE
Sarah Mallagh HSESarah Mallagh HSE
Sarah Mallagh HSE
Kate Jones
 
Wendy Jones Loughborough University
Wendy Jones Loughborough UniversityWendy Jones Loughborough University
Wendy Jones Loughborough University
Kate Jones
 
Pieter van Broekhuizen IVAM
Pieter van Broekhuizen IVAMPieter van Broekhuizen IVAM
Pieter van Broekhuizen IVAM
Kate Jones
 
Kevin English Nanoco
Kevin English NanocoKevin English Nanoco
Kevin English Nanoco
Kate Jones
 
John Saunders HSE
John Saunders HSEJohn Saunders HSE
John Saunders HSE
Kate Jones
 
John Mackenzie Thomas Swan
John Mackenzie Thomas SwanJohn Mackenzie Thomas Swan
John Mackenzie Thomas Swan
Kate Jones
 
James Wheeler HSE
James Wheeler HSEJames Wheeler HSE
James Wheeler HSE
Kate Jones
 
Gareth Evans HSE
Gareth Evans HSEGareth Evans HSE
Gareth Evans HSE
Kate Jones
 
Claire Wienburg University of Bristol
Claire Wienburg University of BristolClaire Wienburg University of Bristol
Claire Wienburg University of Bristol
Kate Jones
 
Delphine Bard HSE
Delphine Bard HSEDelphine Bard HSE
Delphine Bard HSE
Kate Jones
 
Stewart Kowalczyk
Stewart KowalczykStewart Kowalczyk
Stewart Kowalczyk
Kate Jones
 
Kalin
KalinKalin
Kalin
Kate Jones
 
Paton
PatonPaton
Paton
Kate Jones
 
Stuart
StuartStuart
Stuart
Kate Jones
 
Weber
WeberWeber
Weber
Kate Jones
 
10.4 Rossbach
10.4 Rossbach10.4 Rossbach
10.4 Rossbach
Kate Jones
 
11.3 Smolders
11.3 Smolders11.3 Smolders
11.3 Smolders
Kate Jones
 
A.2 Galea
A.2 GaleaA.2 Galea
A.2 Galea
Kate Jones
 

More from Kate Jones (20)

Craig Poland IOM
Craig Poland IOMCraig Poland IOM
Craig Poland IOM
 
Guillaume Flament NIA
Guillaume Flament NIAGuillaume Flament NIA
Guillaume Flament NIA
 
Sarah Mallagh HSE
Sarah Mallagh HSESarah Mallagh HSE
Sarah Mallagh HSE
 
Wendy Jones Loughborough University
Wendy Jones Loughborough UniversityWendy Jones Loughborough University
Wendy Jones Loughborough University
 
Pieter van Broekhuizen IVAM
Pieter van Broekhuizen IVAMPieter van Broekhuizen IVAM
Pieter van Broekhuizen IVAM
 
Kevin English Nanoco
Kevin English NanocoKevin English Nanoco
Kevin English Nanoco
 
John Saunders HSE
John Saunders HSEJohn Saunders HSE
John Saunders HSE
 
John Mackenzie Thomas Swan
John Mackenzie Thomas SwanJohn Mackenzie Thomas Swan
John Mackenzie Thomas Swan
 
James Wheeler HSE
James Wheeler HSEJames Wheeler HSE
James Wheeler HSE
 
Gareth Evans HSE
Gareth Evans HSEGareth Evans HSE
Gareth Evans HSE
 
Claire Wienburg University of Bristol
Claire Wienburg University of BristolClaire Wienburg University of Bristol
Claire Wienburg University of Bristol
 
Delphine Bard HSE
Delphine Bard HSEDelphine Bard HSE
Delphine Bard HSE
 
Stewart Kowalczyk
Stewart KowalczykStewart Kowalczyk
Stewart Kowalczyk
 
Kalin
KalinKalin
Kalin
 
Paton
PatonPaton
Paton
 
Stuart
StuartStuart
Stuart
 
Weber
WeberWeber
Weber
 
10.4 Rossbach
10.4 Rossbach10.4 Rossbach
10.4 Rossbach
 
11.3 Smolders
11.3 Smolders11.3 Smolders
11.3 Smolders
 
A.2 Galea
A.2 GaleaA.2 Galea
A.2 Galea
 

Recently uploaded

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 

Recently uploaded (20)

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 

12.3 pirard